Cellular Origins
Cambridge, GB · Founded 2022 · 99 employees on LinkedIn · 5 known investors
Find your way into Cellular Origins
Sign up to see every warm intro you have to Cellular Origins
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cellular Origins team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cellular Origins provides automated cell therapy manufacturing solutions through its Constellation platform, which integrates robotics and digital management to enable GMP-compliant scaling of cell therapies with minimal process modification.
Founders & leadership
Investors · 5
How we know: Highland Europe's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the Companies House shareholder list · Not right? Tell us
How we know: TTP Ventures's portfolio page · Not right? Tell us
Related companies · 1
Companies working in the same space as Cellular Origins.
Companies House · registry record
View on Companies House ↗- Registered name
- CELLULAR ORIGINS LIMITED
- Company number
- 13910732
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 11 Feb 2022
- Registered office
- Ttp Campus, Cambridge Road, Melbourn, SG8 6HQ
- Nature of business (SIC)
- 72190 — Other research and experimental development on natural sciences and engineering
- Previous names
- CELLULARORIGINS LIMITED (2022–2023)
- Accounts
- last made up to 31 Mar 2025 · next due 31 Dec 2026
- Confirmation statement
- last made up to 10 Feb 2026 · next due 24 Feb 2027
Current officers · 5
- Laurence Roy Garrett — director, appointed 24 Nov 2025
- Samuel Charles William Hyde — director, appointed 22 Jan 2024
- Luke Elliott Rajah — director, appointed 24 Nov 2025
- Edwin James Stone — director, appointed 22 Aug 2023
- Asish Kochuparampil Xavier — director, appointed 24 Nov 2025
Source: Companies House public register · retrieved 24 Jul 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Cellular Origins do?
- Cellular Origins provides automated cell therapy manufacturing solutions through its Constellation platform, which integrates robotics and digital management to enable GMP-compliant scaling of cell therapies with minimal process modification.
- Who are Cellular Origins's investors?
- Cellular Origins's investors include Highland Europe, NYBC Ventures, TTP Ventures, Business Growth Fund, Johnson & Johnson Innovation – JJDC.
- Where is Cellular Origins headquartered?
- Cellular Origins is headquartered in Cambridge, GB.


